Skip to content
lsd.com

Wisconsin

Psychedelic trials in Wisconsin

20 registered trials has a study site in Wisconsin, and 3 are recruiting now.

20
Trials with a site here
3
Recruiting
9
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
The RECAP2 Study: Midazolam and PsilocybinNCT06692192 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
The ENHANCE Study: taVNS and PsilocybinNCT05866471 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
Adjunctive Effects of Psilocybin and a Formulation of BuprenorphineNCT04161066 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1

Facilities

Where the research happens in Wisconsin

FacilityCityTrials
University of WisconsinMadison5
University of Wisconsin - MadisonMadison4
University of Wisconsin at MadisonMadison2
UW School of Medicine and Public HealthMadison1
William S. Middleton Memorial Veterans Hospital, Madison, WIMadison1
University of Wisconsin Medical CenterMadison1
University of Wisconsin Hospital and ClinicsMadison1
UWHealth, 600 Highland AvenueMadison1
University of Wisconsin, School of PharmacyMadison1

Stay told

When a trial opens in Wisconsin

Research alerts

Get a notification when a trial for trials in Wisconsin starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a Wisconsin site

TrialStatusPhaseSubstanceSites
The RECAP2 Study: Midazolam and PsilocybinNCT06692192 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
The ENHANCE Study: taVNS and PsilocybinNCT05866471 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
Adjunctive Effects of Psilocybin and a Formulation of BuprenorphineNCT04161066 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
VA Aripiprazole vs Esketamine for Treatment Resistant DepressionNCT05554627 · VA Office of Research and DevelopmentWithdrawnPhase 4ketamine26
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)NCT03537014 · Resilient PharmaceuticalsCompletedPhase 3mdma15
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)NCT04077437 · Resilient PharmaceuticalsCompletedPhase 3mdma14
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSDNCT04714359 · Resilient PharmaceuticalsCompletedPhase 3mdma15
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionNCT02417064 · Janssen Research & Development, LLCCompletedPhase 3ketamine90
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionNCT02493868 · Janssen Research & Development, LLCCompletedPhase 3ketamine155
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLCCompletedPhase 3ketamine173
54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideNCT03097133 · Janssen Research & Development, LLCCompletedPhase 3ketamine61
A Study of Psilocybin for Major Depressive Disorder (MDD)NCT03866174 · Usona InstituteCompletedPhase 2psilocybin11
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSDNCT03282123 · Resilient PharmaceuticalsCompletedPhase 2mdma12
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell StudyNCT07360301 · University of Wisconsin, MadisonNot yet recruitingPhase 1psilocybin1
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use DisorderNCT05322954 · University of Wisconsin, MadisonTerminatedPhase 1psilocybin1
Consciousness, Psilocybin, and Well-BeingNCT05592379 · University of Wisconsin, MadisonCompletedPhase 1psilocybin1
Pilot RECAP Study in Healthy VolunteersNCT04842045 · University of Wisconsin, MadisonCompletedPhase 1psilocybin1
Bioavailability Study of Psilocybin in Normal AdultsNCT05467761 · University of Wisconsin, MadisonWithdrawnPhase 1psilocybin1
UW Psilocybin Pharmacokinetics StudyNCT02163707 · University of Wisconsin, MadisonCompletedPhase 1psilocybin1
Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)NCT06378528 · University of Wisconsin, MadisonSuspendedEarly Phase 1ketamine1

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states